Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users

Oskar Ayerdi(Hospital Clínico San Carlos), Iria de Domingo, Estefanía Hurtado, Clara Lejarraga(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Natividad Jeréz, Montserrat Raposo(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Petunia Clavo(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Teresa Puerta(Hospital Clínico San Carlos), Mar Vera(Hospital Clínico San Carlos), Manuel Fuentes(Hospital Clínico San Carlos), Juan Ballesteros, Montserrat González, María Teresa Lamata Jiménez, Mónica García, Elisa Torres, Vicente Estrada(Instituto de Salud Carlos III), Carmen Rodríguez(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)
Open Forum Infectious Diseases
September 25, 2020
10.1093/ofid/ofaa455
Cited by 56

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|The Lancet|2006|343
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
|Mucosal Immunology|2014|332